Drug intelligence / Profile preview

TRESUCO

Development stage: Unknown
Lead developer: ADDUCO RBS
Administration: Oral

Overview

TRESUCO is a nutraceutical syrup developed by ADDUCO RBS, specifically formulated to address trace element and antioxidant deficiencies. The product contains a combination of essential minerals, typically including zinc gluconate, copper gluconate, manganese chloride, and sodium selenate. These trace elements function as integral components or cofactors for various enzymes, particularly those involved in the body's antioxidant defense system, such as superoxide dismutase and glutathione peroxidase. By replenishing these micronutrients, TRESUCO helps protect cells from oxidative damage and supports overall metabolic health. It is available as a 100ml syrup for oral administration and is currently approved for use.

Brand names: TRESUCO
Other names: TRESUCO Syrup

Beyond the preview

Go deeper on TRESUCO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRESUCO.

Explore the full profile